Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-08-01 Sale |
2024-08-05 4:36 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Renaud Ronald C JR President & CEO |
244,309 | $0 | $0 | 0 (Indirect Direct) |
View |
| 2023-08-03 Purchase |
2023-08-07 5:13 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Renaud Ronald C JR President & CEO |
83,857 | $23.96 | $2,008,811 | 83,857 (Indirect) |
View |
| 2021-09-14 Sale |
2021-09-14 7:32 pm |
Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer |
954,053 | $38 | $36,254,014 | 0 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-10-10 Option Award |
2024-10-15 4:15 pm |
N/A 2034-10-09 |
Upstream Bio Inc. | UPB | Renaud Ronald C JR Director |
17,096 | $0 | 17,096 (Direct) |
View |
Ownership |
2024-10-10 8:09 pm |
N/A 2032-01-01 |
Upstream Bio Inc. | UPB | Renaud Ronald C JR Director |
0 | $0 | 426,401 (Direct) |
View |
| 2024-01-19 Option Award |
2024-01-23 5:31 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Renaud Ronald C JR President & CEO |
284,023 | $0 | 284,023 (Direct) |
View |
| 2023-12-19 Exercise |
2023-12-21 8:18 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Renaud Ronald C JR President & CEO |
160,452 | $0 | 244,309 (Direct) |
View |
| 2023-06-12 Option Award |
2023-06-14 4:53 pm |
N/A 2033-06-12 |
Cerevel Therapeutics Holdings Inc. | CERE | Renaud Ronald C JR President & CEO |
536,572 | $0 | 536,572 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-27 4:48 pm |
N/A 2032-06-22 |
Atara Biotherapeutics Inc. | ATRA | Renaud Ronald C JR Director |
52,000 | $0 | 63,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 6:09 pm |
N/A 2032-06-09 |
Ikena Oncology Inc. | IKNA | Renaud Ronald C JR Director |
13,419 | $0 | 13,419 (Direct) |
View |
| 2021-12-21 Option Award |
2021-12-23 6:35 pm |
N/A 2031-12-21 |
Ikena Oncology Inc. | IKNA | Renaud Ronald C JR Director |
13,419 | $0 | 13,419 (Direct) |
View |
| 2021-04-07 Exercise(A) |
2021-09-14 7:31 pm |
N/A N/A |
Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer |
9,026 | $7.39 | 2,025,062 (Direct) |
View |
| 2021-04-07 Exercise(A) |
2021-09-14 7:31 pm |
N/A 2027-12-21 |
Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer |
9,026 | $0 | 2,025,062 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-09 7:13 pm |
N/A 2031-06-07 |
Atara Biotherapeutics Inc. | ATRA | Renaud Ronald C JR Director |
28,500 | $0 | 28,500 (Direct) |
View |
| 2021-04-07 Exercise |
2021-04-09 4:14 pm |
N/A N/A |
Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer |
9,026 | $7.39 | 2,025,152 (Direct) |
View |
| 2021-04-07 Exercise |
2021-04-09 4:14 pm |
N/A 2027-12-21 |
Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer |
9,026 | $0 | 2,025,152 (Direct) |
View |
Ownership |
2021-03-25 8:11 pm |
N/A 2028-05-09 |
Ikena Oncology Inc. | IKNA | Renaud Ronald C JR Director |
0 | $0 | 223,840 (Direct) |
View |
| 2021-03-09 Option Award |
2021-03-09 8:27 pm |
N/A 2031-03-09 |
Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer, Pres. |
325,000 | $0 | 325,000 (Direct) |
View |
| 2021-01-14 Exercise |
2021-01-14 7:59 pm |
N/A N/A |
Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer, Pres. |
1 | $8.34 | 2,115,058 (Direct) |
View |
| 2021-01-14 Exercise |
2021-01-14 7:59 pm |
N/A N/A |
Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer, Pres. |
5,638 | $7.39 | 2,115,058 (Direct) |
View |
| 2021-01-14 Exercise |
2021-01-14 7:59 pm |
N/A 2027-12-21 |
Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer, Pres. |
5,639 | $0 | 2,115,058 (Direct) |
View |
| 2020-11-16 Exercise |
2020-11-18 7:30 pm |
N/A N/A |
Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer, Pres. |
3 | $8.34 | 2,115,058 (Direct) |
View |
| 2020-11-16 Exercise |
2020-11-18 7:30 pm |
N/A N/A |
Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer, Pres. |
53,004 | $7.39 | 2,115,058 (Direct) |
View |
| 2020-11-16 Exercise |
2020-11-18 7:30 pm |
N/A 2027-12-21 |
Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer, Pres. |
53,007 | $0 | 2,115,058 (Direct) |
View |
| 2020-04-29 Option Award |
2020-04-30 7:44 pm |
N/A 2030-04-28 |
Atara Biotherapeutics Inc. | ATRA | Renaud Ronald C JR Director |
71,500 | $0 | 71,500 (Direct) |
View |